-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Dentsply Sirona, Maintains $14 Price Target

Benzinga·12/16/2025 15:30:58
Listen to the news
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and maintains $14 price target.